A gingipain-active extracellular protein/protease fraction from Porphyromonas gingivalis promotes epithelial CCL20 expression and γδ T-cell accumulation in COPD-like airways
Journal of Pharmacological Sciences · 2026-12 · 162 (4) · 346-359
DOI: 10.1016/j.jphs.2026.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2026-12. Verfasst von Keisuke Kawano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japa…. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Chemokine CCL20, Pulmonary Disease, Chronic Obstructive, Gene Expression. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology, Japan Society for the Promotion of Science, The Pharmaceutical Society of Japan.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory airway disease in which impaired mucosal barrier function may increase susceptibility to aspirated oral microbial products. Periodontal disease is associated with COPD development and exacerbation, but the epithelial mechanisms linking periodontal pathogens to pulmonary inflammation remain unclear. Here, we investigated whether a gingipain-active Porphyromonas gingivalis (P. gingivalis) extracellular protein/protease fraction (PCS) promotes γδ T-cell-associated inflammation in COPD-like airways. Repeated intratracheal PCS administration to epithelial sodium channel β-subunit (βENaC)-transgenic mice increased γδ T-cell accumulation and pulmonary Ifng, Il17a, Ccl20, and Ccr6 mRNA expression, without coordinated induction of M2-associated markers. Pulmonary Tslp and Il18 mRNA were not significantly altered. Serum CCL20 concentrations increased in both wild-type and βENaC-transgenic mice. In β/γENaC-overexpressing human airway epithelial cells, PCS increased mRNA expression of CCL20 and F2RL1, encoding protease-activated receptor 2 (PAR-2), and reduced PAR-2 immunoreactivity. PAR-2 agonist stimulation induced CCL20 expression, whereas PAR-2 inhibition suppressed PCS-induced expression. PAR-1 inhibition or lipopolysaccharide neutralization did not significantly suppress this response. Heat treatment of PCS reduced gingipain activities to background levels and attenuated PCS-induced CCL20 mRNA expression. These findings support epithelial PAR-2-associated CCL20 induction as a potential link between periodontal bacterial products and γδ T-cell-associated inflammation in COPD-like airways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Program for Fostering Innovators to Lead a Better Co-being Society,…
- Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan; Health Life Science S-HIGO Professional Fellowship Program, Kumamot…
- Department of Food Science & Nutrition, Beppu University, 82 Kitaishigaki, Beppu, Oita, 874-8501, Japan.
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjyo, Chuo-ku, Kumamoto, 860-8556, Japan.
- Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.
- Laboratory of Pharmacology, Division of Life Science, Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1 Ikeda, Nishi-ku, Kumamoto, 860-0082, Japan.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
- Japan Society for the Promotion of Science
- The Pharmaceutical Society of Japan
Zitieren
APA
Kawano, K., Takahashi, N., Kishimoto, T., Kariu, T., Fujiwara, Y., Uemura, M., Nakajima, K., Kinjo, N., Ueno-Shuto, K., Nakashima, R., Hayashi, M., Suico, M. A., & Shuto, T. (2026). A gingipain-active extracellular protein/protease fraction from Porphyromonas gingivalis promotes epithelial CCL20 expression and γδ T-cell accumulation in COPD-like airways. Journal of Pharmacological Sciences, 162(4), 346-359. https://doi.org/10.1016/j.jphs.2026.10.005
Vancouver
Kawano K, Takahashi N, Kishimoto T, Kariu T, Fujiwara Y, Uemura M, et al. A gingipain-active extracellular protein/protease fraction from Porphyromonas gingivalis promotes epithelial CCL20 expression and γδ T-cell accumulation in COPD-like airways. Journal of Pharmacological Sciences. 2026;162(4):346-359. doi:10.1016/j.jphs.2026.10.005
BibTeX
@article{Kawano2026,
author = {Kawano, Keisuke and Takahashi, Noriki and Kishimoto, Tomoki and Kariu, Toru and Fujiwara, Yukio and Uemura, Mai and Nakajima, Kota and Kinjo, Nodoka and Ueno-Shuto, Keiko and Nakashima, Ryunosuke and Hayashi, Megumi and Suico, Mary Ann and Shuto, Tsuyoshi},
title = {A gingipain-active extracellular protein/protease fraction from Porphyromonas gingivalis promotes epithelial CCL20 expression and γδ T-cell accumulation in COPD-like airways},
journal = {Journal of Pharmacological Sciences},
year = {2026},
volume = {162},
number = {4},
pages = {346--359},
doi = {10.1016/j.jphs.2026.10.005}
}
EUVIMED